A novel pharmaceutical composition comprising the NK.sub.3 receptor antagonist talnetant, povidone, mannitol and a surfactant, and a process for its preparation are disclosed.

 
Web www.patentalert.com

< Methods for treating podocyte-related disorders

> Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine
~ 00470